Portolan Capital Management - Q4 2021 holdings

$1.49 Billion is the total value of Portolan Capital Management's 131 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .

 Value Shares↓ Weighting
AMTX  AEMETIS, INC.$1,305,000
-32.7%
106,0900.0%0.09%
-37.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

About Portolan Capital Management

Portolan Capital Management is a New York-based investment management firm that specializes in long/short equity strategies. The firm was founded in 2002 by George McCabe, who serves as the Chief Investment Officer. McCabe has over 30 years of experience in the investment industry, having previously worked at firms such as Goldman Sachs and J.P. Morgan.

Portolan's investment philosophy is based on fundamental research and a disciplined approach to risk management. The firm's investment team conducts extensive research on companies and industries to identify undervalued securities with strong growth potential. They also use a variety of quantitative tools to manage risk and optimize portfolio construction.

In addition to McCabe, Portolan's leadership team includes Chief Operating Officer Michael McCabe and Chief Financial Officer John McCabe. The firm has a team of experienced investment professionals who work together to manage the firm's portfolios.

Portolan's investment strategies have delivered strong performance over the years, with a focus on generating alpha through stock selection and risk management. The firm's long/short equity strategy has consistently outperformed its benchmark, with a track record of strong risk-adjusted returns.

Overall, Portolan Capital Management is a well-respected investment management firm with a strong track record of delivering value to its clients. With a focus on fundamental research and disciplined risk management, the firm is well-positioned to continue delivering strong performance in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CASELLA WASTE SYSTEMS, INC. CLASS A42Q3 20235.3%
META PLATFORMS, INC.41Q3 20232.0%
ABIOMED INC CMN38Q3 20222.9%
ANIKA THERAPEUTICS INC CMN36Q2 20232.8%
BIO-RAD LABORATORIES, INC.34Q3 20233.5%
EURONET WORLDWIDE INC CMN32Q4 20223.9%
ALPHABET, INC.32Q3 20233.3%
SKECHERS USA, INC.31Q3 20232.9%
QUALYS INC CMN30Q4 20222.6%
ELECTRONIC ARTS, INC.29Q4 20222.2%

View Portolan Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Portolan Capital Management Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ALTA EQUIPMENT GROUP INC.February 13, 2023572,2461.8%
Charah Solutions, Inc.February 13, 2023166,8195.0%
FULL HOUSE RESORTS INCFebruary 13, 2023407,4521.2%
HARVARD BIOSCIENCE INCFebruary 13, 20231,054,3002.5%
LANTRONIX INCFebruary 13, 2023691,1181.9%
RICHARDSON ELECTRONICS, LTD.February 13, 2023484,6324.0%
Charah Solutions, Inc.November 22, 20221,782,0525.3%
APPLIED GENETIC TECHNOLOGIES CORPFebruary 15, 20222,218,1885.2%
AEMETIS, INCFebruary 11, 2022106,0900.3%
BlueLinx Holdings Inc.February 11, 2022451,7934.6%

View Portolan Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-14
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2023-12-18
13F-HR2023-11-14

View Portolan Capital Management's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1486875000.0 != 1486874000.0)

Export Portolan Capital Management's holdings